Burls, Caron, Cleret de Langavant, et al.,”Tackling ethical issues in health technology assessment: A proposed framework," IJTAHC 27 (July 2011), 230-237.

The following papers were also nominated as finalists for the award:

• Mitchell, Williams, Kuntz & Umscheid. “When the decision is what to decide: Using evidence inventory reports to focus health technology assessments” (Issue 2)
• van der Wilt, Groenewoud & van Riel. “Bridging the gap between aggregate data and individual patient management: A Bayesian approach”(Issue 2)

Koopmanschap, Stolk &  Koolman. "Dear policy maker: Have you made up your mind? A discrete choice experiment among policy makers and other health professionals," IJTAHC 26 (April 2010), 198-204.

The following papers were also nominated as finalists for the award:

• Craig, McDaid, Fonseca, et al., "Are adverse effects incorporated in economic models? A survey of current practice" (Issue 3)
• Droste, Dintsios & Gerber, "Information on ethical issues in health technology assessment: How and where to find them" (Issue 4)

P Trueman et al., "The feasibility of harmonizing health technology assessments across jurisdictions: A case study of drug eluting stents," IJTAHC 25 (October 2009), 455-462.

The following papers were also nominated as finalists for the award:

• J Elston et al., “Use of surrogate outcomes in cost-effectiveness models: A review of UK HTA Reports” (Issue 1)
• MGH Nizen et al., “Finding legitimacy for the role of budget impact in drug reimbursement decisions” (Issue 1)
• I Dhalla et al., “Perspectives on NICE’s recommendations to use health technologies only in research” (Issue 3)
• M Velasco Garrido et sal., “Surrogate outcomes in HTA: an international comparison” (Issue 3)
• J Glanville et al., “How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE” (Issue 4)